SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001558370-22-005318
Filing Date
2022-04-12
Accepted
2022-04-12 16:02:04
Documents
14

Document Format Files

Seq Description Document Type Size
1 F-3 tmb-20220407xf3.htm F-3 625504
2 EX-1.2 tmb-20220407xex1d2.htm EX-1.2 361276
3 EX-4.2 tmb-20220407xex4d2.htm EX-4.2 429111
4 EX-5.1 tmb-20220407xex5d1.htm EX-5.1 98362
5 EX-5.2 tmb-20220407xex5d2.htm EX-5.2 28498
6 EX-23.1 tmb-20220407xex23d1.htm EX-23.1 3491
7 EX-FILING FEES tmb-20220407xexfilingfees.htm EX-FILING FEES 145272
8 GRAPHIC tmb-20220407xf3005.jpg GRAPHIC 8998
9 GRAPHIC tmb-20220407xf3003.jpg GRAPHIC 5448
10 GRAPHIC tmb-20220407xf3006.jpg GRAPHIC 55461
11 GRAPHIC tmb-20220407xf3004.jpg GRAPHIC 31425
12 GRAPHIC tmb-20220407xex5d1002.jpg GRAPHIC 3145
13 GRAPHIC tmb-20220407xex5d2002.jpg GRAPHIC 5451
14 GRAPHIC tmb-20220407xex5d2001.jpg GRAPHIC 3551
  Complete submission text file 0001558370-22-005318.txt   1849911
Mailing Address YALELAAN 60 UTRECHT P7 3584 CM
Business Address YALELAAN 60 UTRECHT P7 3584 CM 31 6 3000 3035
LAVA Therapeutics NV (Filer) CIK: 0001840748 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-264246 | Film No.: 22822250
SIC: 2834 Pharmaceutical Preparations